SEC Filing Summary: Graphite Bio, Inc. (GRPH)
Business Context and Reporting Period
This Form 8-K was filed by Graphite Bio, Inc. on December 8, 2021, reporting events occurring on December 6, 2021. The registrant is an emerging growth company incorporated in Delaware, with its principal executive offices in South San Francisco, CA. The filing addresses Item 5.02 regarding the departure of a certain officer.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report focuses exclusively on corporate governance and personnel changes rather than financial performance.
Material Changes
The primary material change reported is the departure of Katherine V. Stultz, the Company's Chief Operating Officer. Ms. Stultz and the Company agreed that her employment will end effective as of the close of business on December 31, 2021.
Guidance, Outlook, and Risks
The filing contains no management commentary regarding financial guidance, future outlook, or specific risk factors. The document is limited to the notification of the executive departure.
Investor Verification Checklist
- Verify the effective date of Katherine V. Stultz's departure (December 31, 2021).
- Confirm whether a successor Chief Operating Officer has been appointed or if the role is being reassigned.
- Review subsequent filings for any impact of this leadership change on the Company's operational strategy.